Abstract
Preexisting CKD may affect the severity of and/or recovery from AKI. We assessed the impact of prior graded normotensive renal mass reduction on ischemia-reperfusion–induced AKI. Rats underwent 40 minutes of ischemia 2 weeks after right uninephrectomy and surgical excision of both poles of the left kidney (75% reduction of renal mass), right uninephrectomy (50% reduction of renal mass), or sham reduction of renal mass. The severity of AKI was comparable among groups, which was reflected by similarly increased serum creatinine (SCr; approximately 4.5 mg/dl) at 2 days, tubule necrosis at 3 days, and vimentin-expressing regenerating tubules at 7 days postischemia-reperfusion. However, SCr remained elevated compared with preischemia-reperfusion values, and more tubules failed to differentiate during late recovery 4 weeks after ischemia-reperfusion in rats with 75% renal mass reduction relative to other groups. Tubules that failed to differentiate continued to produce vimentin, exhibited vicarious proliferative signaling, and expressed less vascular endothelial growth factor but more profibrotic peptides. The disproportionate failure of regenerating tubules to redifferentiate in rats with 75% renal mass reduction associated with more severe capillary rarefaction and greater tubulointerstitial fibrosis. Furthermore, initially normotensive rats with 75% renal mass reduction developed hypertension and proteinuria, 2–4 weeks postischemia-reperfusion. In summary, severe (>50%) renal mass reduction disproportionately compromised tubule repair, diminished capillary density, and promoted fibrosis with hypertension after ischemia-reperfusion–induced AKI in rats, suggesting that accelerated declines of renal function may occur after AKI in patients with preexisting CKD.
Clinical studies suggest that AKI worsens preexisting CKD and accelerates progression to end stage because of residual structural and functional deficits.1–7 CKD, per se, may increase the risk and severity of AKI and the likelihood of incomplete recovery from AKI.8 Thus, AKI and CKD reinforce each other to increase nephron loss and tubulointerstitial fibrosis (TIF).9 Nevertheless, causal relationships for both aspects of the AKI–CKD nexus10 (AKI resulting in CKD/ESRD and CKD, per se, predisposing to AKI) have been questioned.11,12 These concerns were recently reviewed.13 AKI–CKD relationships have also been questioned on the grounds that mechanisms for AKI–CKD interactions are ill-defined and controversial.14–16
We addressed these uncertainties by investigating the impact of normotensive renal mass reduction (RMR; 0%, 50%, and 75%) of 2-weeks duration on AKI induced by ischemia-reperfusion (I/R) in rats. We addressed three questions. (1) Does prior RMR increase AKI severity? (2) Does prior RMR impair recovery from AKI? (3) Does prior RMR predispose to the development of more severe TIF during recovery from AKI? To achieve 75% RMR, we used the normotensive rat remnant kidney model produced by uninephrectomy and excision of approximately one half of the contralateral kidney.17 Normotensive 75% RMR, per se, causes minimal TIF even after 4 months,17–19 despite adaptations (e.g., glomerular hyperfiltration, hypertrophy, oxidative stress, etc.) that are postulated to cause fibrosis in hypertensive RMR models.20–22
Results
The effects of AKI on body and kidney weights followed expected patterns (Table 1).
Table 1.
Effect of I/R-induced AKI on body and kidney weights
| Group | Body Weight (g) | Total Kidney Weight (g) | Kidney Weight/ Body Weight (g/kg) | |
|---|---|---|---|---|
| Baseline | Final | |||
| Bilateral I/R (n=10) | 328±17 | 431±14a | 6.3±0.2b | 14.8±0.7b |
| UNX I/R (n=12) | 338±4 | 431±5a | 4.7±0.2b | 10.9±0.6 |
| 3/4 NX I/R (n=12) | 309±11 | 365±14a,b | 3.6±0.2 | 10.2±0.8 |
| 3/4 NX sham I/R (n=5) | 287±13 | 473±21a | 2.9±0.2 | 6.0±0.3b |
Pre-I/R body weights obtained approximately 2 weeks after RMR were not different among groups. Increases in weight gain after 4 weeks were observed in all groups but to a significantly lesser extent in the 3/4 NX I/R rats. Absolute kidney weights exhibited the expected pattern with graded RMR. Compared with the 3/4 NX sham I/R rats, kidney weights tended to be higher in 3/4 NX I/R rats but did not reach statistical significance (P=0.06). However, when normalized to body weight, relative kidney weights were significantly greater in 3/4 NX I/R versus 3/4 NX sham I/R rats. Values are mean±SEM.
P<0.05 versus respective baseline body weight.
P<0.05 versus all other groups.
RMR Does Not Modify Acute Serum Creatinine Increases or Acute Tubular Necrosis after I/R
Two weeks of RMR resulted in modest serum creatinine (SCr) increases before I/R in proportion to lost renal mass (pre-I/R) (Figure 1). However, 48 hours post-I/R, SCr was comparably elevated (approximately 4.5 mg/dl) in all groups, suggesting similar AKI severity. Acute tubular necrosis 3 days after I/R was higher in the outer stripe of outer medulla versus cortex in all groups (n=5 each) but not different between bilateral, uninephrectomy (UNX), and 3/4 nephrectomy (3/4 NX) groups (Figure 2).
Figure 1.
Similar severity, but impaired recovery of SCr after AKI in 3/4 NX rats. SCr before and 48 hours, 1 week, and 4 weeks after I/R injury. The expected baseline (pre-I/R) differences (P<0.05) in SCr (milligrams per deciliter) were observed with bilateral < UNX < 3/4 NX groups (significance not indicated on the graph for clarity issues). Although similar elevations in SCr were observed in all I/R groups, with no intergroup differences at 48 hours post-I/R (*P<0.05 versus respective pre-I/R values), recovery of SCr to baseline levels was attenuated in 3/4 NX I/R, which was evidenced by higher SCr at 1 and 4 weeks post-I/R (#P<0.05 versus other I/R groups at similar time points and versus respective pre-I/R values). Values are mean±SEM.
Figure 2.
Degree of RMR does not modify the severity of acute tubular necrosis after I/R. (A) Representative images (Hematoxylin and Eosin) illustrating acute tubular necrosis in bilateral, UNX, and 3/4 NX groups at 3 days post-I/R. OSOM, outer stripe of outer medulla. (B) Semiquantitative analysis of acute tubular necrosis in bilateral (n=5), UNX (n=5), and 3/4 NX (n=5) rats at 3 days after I/R. The severity of tubular necrosis was greater in OSOM versus cortex in all groups (†P<0.05; †††P<0.001 versus respective cortex value). However, I/R injury led to similar levels of acute tubular necrosis in all groups within the OSOM and cortex. Values are mean±SEM. Scale bar, 1 mm.
RMR by 3/4 NX Delays Functional Recovery and Predisposes to Severe TIF 4 Weeks after I/R
After acute increases, SCr declined in all groups by 1 week and then, declined to lower levels by 4 weeks; however, SCr remained higher in 3/4 NX I/R (n=12) rats at 1 and 4 weeks compared with values for pre-I/R and UNX I/R (n=12) or bilateral I/R (n=10) rats (Figure 1). Four weeks after I/R, all kidneys showed patchy TIF greater than the minimal fibrosis in 3/4 NX sham I/R kidneys (Figure 3A). However, corresponding to incomplete recovery of SCr, TIF was more severe in 3/4 NX I/R rats than UNX and bilateral I/R rats, which did not differ between themselves (Figure 3B). Thus, 3/4 NX predisposed to greater TIF 4 weeks after I/R, despite similarly severe AKI in all groups. Dissociation between AKI severity and recovery is supported by the weak correlation between SCr at 48 hours post-I/R and TIF at 4 weeks post-I/R in the same animals (Supplemental Figure 1). In 5 of 12 3/4 NX I/R rats, TIF severity approached end stage.
Figure 3.
Greater severity of TIF 4 weeks after I/R in 3/4 NX rats. TIF 4 weeks after I/R injury or sham I/R surgery. Representative Masson’s Trichrome images are shown in A and show extensive fibrosis and tubular atrophy in 3/4 NX rats subjected to I/R injury. TIF was patchy and variable in both the bilateral and UNX groups subjected to I/R injury. Semiquantitative analysis of TIF is shown in B and shows greater levels in kidneys from 3/4 NX I/R rats (**P<0.01 versus 3/4 NX I/R). TIF score is provided for 3/4 NX sham I/R rats, but it was not used in the statistical analyses. Values are mean±SEM. Scale bar, 1 mm.
TIF 4 Weeks after I/R in 3/4 NX RMR Rats Is Associated with Persistent Profibrotic Signaling in Greater Numbers of Regenerating Tubules That Fail to Redifferentiate
We and others have previously shown that TIF after AKI is associated with failed redifferentiation of regenerating tubule epithelium that continues to secrete profibrotic peptides.9,23–29 To investigate whether RMR deters regenerating proximal tubules (PTs) from differentiating during recovery from I/R, we performed immunohistochemistry (IHC) for vimentin. Absent in normal PTs, vimentin becomes expressed when surviving cells dedifferentiate and proliferate after AKI.30–34 As tubules redifferentiate, vimentin expression is suppressed.31 Therefore, vimentin expression in tubules late after injury (when recovery should be complete) indicates defective repair with abnormally dedifferentiated epithelium.26,27,31,33
Accordingly, 7 days post-I/R, tubules expressed vimentin in proportion to necrosis at 3 days (Figure 4A), with sharp transitions between epithelium without and with vimentin (Supplemental Figure 2A). As expected, 3/4 NX sham I/R kidneys showed staining only in glomeruli and interstitial fibroblasts. Vimentin-positive tubules were more numerous in the outer stripe of outer medulla than cortex, without differences between bilateral I/R (n=5), UNX I/R (n=5), and 3/4 NX I/R (n=5) groups 7 days post-I/R (Figure 4C), which parallels similar severities of acute injury.
Figure 4.
Greater failure of tubules to redifferentiate 4 weeks after I/R in 3/4 NX rats, as indicated by vimentin positivity. Tubular vimentin expression in (A and C) bilateral (n=5), UNX (n=5), and 3/4 NX (n=5) groups at 7 days and (B and D) bilateral (n=10), UNX (n=12), and 3/4 NX (n=12) groups at 4 weeks after I/R. Tubules regenerating after I/R injury express vimentin at 7 days (early after I/R) and thus, can be used as an index of the severity of AKI. As shown in A and C and similar to the pattern of acute tubular necrosis, tubular vimentin expression was greater in OSOM versus cortex in all groups but without significant differences between groups. Vimentin staining is absent in tubules but normally expressed in glomeruli and interstitial fibroblasts in 3/4 NX sham I/R kidneys. Additional evidence supporting the use of vimentin as an index of regenerating tubules after AKI is illustrated in Supplemental Figure 2. As shown in B and D, 4 weeks after I/R, vimentin-positive tubules declined relative to (A and C) those tubules seen at 1 week in different groups of bilateral and UNX I/R rats, suggesting that significant numbers of tubules had redifferentiated. However, vimentin-positive tubules in the 3/4 NX I/R group remained elevated at 4 weeks versus bilateral and UNX I/R groups, paralleling the TIF grades (Figure 3). E shows the linear regression analysis between TIF and vimentin-positive tubules (average score from OSOM and cortex) at 4 weeks after I/R in the same bilateral (n=10), UNX (n=12), and 3/4 NX (n=12) I/R rats. A strong (r2=0.80) and significant (P<0.001) correlation between the extent of vimentin-expressing tubules and the level of TIF is evident. †P<0.05; ††P<0.01 versus respective cortex value. *P<0.05; **P<0.01 versus the respective 3/4 NX I/R group. Values are mean±SEM. Scale bar, 1 mm.
As shown in Figure 4B, vimentin-positive tubules at 4 weeks post-I/R declined in all groups relative to 7 days post-I/R (Figure 4A). However, although kidneys in all I/R groups showed persistent vimentin expression in substantial numbers of tubules and fibroblasts at 4 weeks post-I/R, such tubules were significantly higher in 3/4 NX (n=12) versus bilateral (n=10) and UNX (n=12) I/R kidneys (Figure 4D). Most vimentin-positive tubules were undifferentiated and atrophic, with sharp transitions between cells without vimentin and vice versa (Supplemental Figure 2B). Vimentin positivity at 4 weeks post-I/R was highly correlated (r2=0.80, P<0.001) with corresponding TIF scores (Figure 4E).
We validated vimentin as a marker for failed differentiation, vicarious signaling, and profibrotic peptide expression. Serial sections showed increased phospho-c-Jun in the same vimentin-positive tubules (Figure 5A, Supplemental Figure 3A). Sham I/R kidneys showed only occasional phospho-c-Jun–positive nuclei (Figure 5A). c-Jun is phosphorylated by Jun N-terminal kinase that is activated within minutes of I/R and suppressed during recovery,35 unless tubule repair becomes compromised and TIF develops.26 Thus, vimentin-positive tubules associated with TIF 4 weeks after I/R pathologically retained signaling activity that is initiated earlier during proliferation. They also exhibited a lack of differentiation markers, which was reflected by the lack of phytohaemagglutinin-E–lectin–bound brush borders and the lack of Na+K+-ATPase staining in basolateral membranes (Figure 5B, Supplemental Figure 3B). The same tubules showed increased immunostaining for connective tissue growth factor (Figure 5B, Supplemental Figure 3B), PDGF-B, and TGFβ1 (not shown).
Figure 5.
Vimentin-positive tubules exhibit lack of differentiation markers, but persistent profibrotic signaling, 4 weeks after I/R. (A) Representative IHC images for vimentin (Vim; brown) and phospho-c-Jun (p-cJun; red) in serial sections from 3/4 NX kidneys 4 weeks after I/R or sham I/R surgery. Increased nuclear phospho-c-Jun was present in the same tubules that expressed vimentin in kidneys from 3/4 NX I/R rats, whereas 3/4 NX sham I/R kidneys showed only occasional phospho-c-Jun–positive nuclei. Transcription factor c-Jun is phosphorylated in tubules within minutes of I/R and suppressed during recovery. Abundance of tubules coexpressing vimentin and phospho-c-Jun at 4 weeks post-I/R, when such signaling should be abated, is indicative of a dedifferentiated, persistently signaling profibrotic phenotype consistent with impaired recovery from AKI. Similar patterns of tubular vimentin and phospho-c-Jun expression were observed in bilateral and UNX kidneys at 4 weeks after I/R, although to a lesser extent (Supplemental Figure 3A). B shows representative IHC images for vimentin (brown)–phytohaemagglutinin-E–lectin (red) costaining, Na+K+-ATPase, and connective tissue growth factor (CTGF) in serial sections from 3/4 NX kidneys 4 weeks after I/R or sham I/R surgery. Numerous tubules in 3/4 NX I/R kidneys expressed vimentin, lacked the brush border and basolateral membrane differentiation markers PHAE-lectin and Na+K+-ATPase, respectively, and showed increased staining for profibrotic peptide CTGF. Kidneys of 3/4 NX sham I/R rats exhibited robust tubule PHAE-lectin and Na+K+-ATPase expression with minimal CTGF staining. The vimentin-positive tubules in the 3/4 NX I/R rats are consistent with the dedifferentiated, persistently signaling profibrotic phenotype associated with impaired recovery from AKI that we have previously described.26 Of note, a similar profibrotic, dedifferentiated tubule phenotype was observed in both bilateral and UNX groups at 4 weeks after I/R, although to a lesser extent compared with 3/4 NX I/R rats (Supplemental Figure 3B). Scale bar, 100 µm.
We performed additional quantitative validation of the lack of differentiation markers in vimentin-expressing tubules by grading PT expression of aquaporin 1 (AQP1), which is normally abundantly expressed in amplified brush border and basolateral membranes of PT. Tubules lost AQP1 more severely in 3/4 NX I/R kidneys than bilateral I/R and UNX I/R kidneys (Figures 6 and 7A, Supplemental Figure 4). Furthermore, we assessed phosphatase and tensin homolog (PTEN) expression in tubules (Figures 6 and 7B, Supplemental Figure 4). PTEN regulates PT differentiation and is lost from the undifferentiated vimentin-positive tubules during TIF development after I/R.26 The highly significant (P<0.001) inverse relationships and strong correlations between vimentin positivity and AQP1 (r2=0.92) and between vimentin positivity and PTEN (r2=0.91) are shown in Figure 7, C and D, respectively. Similar inverse relationships were also observed between AQP1 and TIF (r2=0.77, P<0.001) (Supplemental Figure 5A) and PTEN and TIF (r2=0.75, P<0.001) (Supplemental Figure 5B).
Figure 6.
Severe and parallel loss of tubular differentiation markers and PTEN positivity 4 weeks after I/R. Representative IHC images for AQP1 and PTEN from 3/4 NX kidneys 4 weeks after I/R or sham I/R surgery. Because healthy, differentiated PTs normally express abundant AQP1 in brush border and basolateral membranes, ample levels of AQP1 were seen in PTs of 3/4 NX sham I/R kidneys. However, PTs from 3/4 NX I/R kidneys exhibited substantial reductions in AQP1, indicating a sustained undifferentiated phenotype. Similar reductions in AQP1 expression were also observed in bilateral and UNX kidneys 4 weeks after I/R, although to a lesser extent (Supplemental Figure 4). Similar to the pattern of AQP1 expression, PTEN levels in PTs were lower in 3/4 NX I/R versus 3/4 NX sham I/R kidneys. As we have previously described, PTEN regulates PT differentiation, and such decreases in PTEN also indicate a heightened state of dedifferentiation in tubules 4 weeks after I/R, when tubules should have redifferentiated. Of note, a similar pattern of PTEN reduction was observed in bilateral and UNX kidneys 4 weeks after I/R, although to a lesser extent (Supplemental Figure 4). Scale bar, 100 µm.
Figure 7.
Strong correlations are observed between tubular vimentin positivity and loss of AQP1 and PTEN 4 weeks after I/R. Semiquantitative analysis of (A) AQP1 and (B) PTEN in PTs from bilateral (n=10), UNX (n=12), and 3/4 NX (n=12) rats 4 weeks after I/R. Significant reductions in AQP1 were seen in PTs from 3/4 NX I/R versus other I/R kidneys. A similar tendency for decreased PTEN levels in PTs from 3/4 NX I/R kidneys was also noted. AQP1 and PTEN were abundantly expressed in bilateral, UNX, and 3/4 NX sham I/R kidneys (all scores of five; data not shown). The use of vimentin, AQP1, and PTEN IHC analyses as evidence of failed redifferentiation in PTs after I/R injury is shown by the very strong correlations between (C) AQP1–vimentin (r2=0.92, P<0.001) and (D) PTEN–vimentin (r2=0.91, P<0.001). **P<0.01 versus respective 3/4 NX I/R group. Values are mean±SEM.
Increased TIF in 3/4 NX I/R Kidneys Is Accompanied by Markedly Decreased Expression of VEGF in Tubules and Increased Rarefaction of Peritubular Capillaries Compared with Bilateral I/R and UNX I/R Groups
Because diminished tubule vascular endothelial growth factor (VEGF) expression, microvascular rarefaction, and tissue hypoxia may promote TIF after I/R injury and fibrotic renal disease,36–45 we assessed VEGF and microvascular density (Figure 8, Supplemental Figure 6). IHC using an antibody recognizing all VEGF-A isoforms showed staining in tubules but not interstitial cells. Tubule VEGF was more severely decreased in 3/4 NX I/R kidneys (Figure 9A) together with markedly increased capillary rarefaction (reduced epithelium aminopeptidase P [JG12] staining) by quantitative grading compared with the other groups (Figure 9B). Scores for vimentin positivity exhibited a strong inverse correlation (r2=0.67, P<0.001) with tubular VEGF expression (Figure 9C). Scores for tubule VEGF were strongly correlated (r2=0.76, P<0.001) with JG12 scores (Figure 9D). Scores for VEGF (Supplemental Figure 7A) and JG12 (Supplemental Figure 7B) also exhibited strong inverse correlations with corresponding TIF grades.
Figure 8.
Severe and parallel loss of tubular VEGF and peritubular capillaries 4 weeks after I/R. Representative IHC images for epithelial VEGF (all VEGF-A isoforms) and endothelial aminopeptidase P (JG12 antibody) from 3/4 NX kidneys 4 weeks after I/R or sham I/R surgery. VEGF staining was present in tubules but not interstitial cells. Marked reductions in VEGF expression were seen in kidneys from 3/4 NX I/R rats versus 3/4 NX sham I/R rats and both bilateral and UNX I/R rats, which exhibited a similar pattern of decreased VEGF staining, although to a lesser extent (Supplemental Figure 6). JG12 staining was used to mark capillary endothelium. Decreased capillary density inferred from JG12-stained structures was observed in fibrotic tissue around atrophic tubules 4 weeks after I/R in 3/4 NX rats. In contrast, robust JG12 staining was observed in 3/4 NX sham I/R kidneys. A similar pattern of decreased JG12 staining in fibrotic tissue with atrophic tubules was also seen in bilateral and UNX kidneys 4 weeks after I/R, although to a lesser extent (Supplemental Figure 6). Scale bar, 100 µm.
Figure 9.
Strong correlative interrelationships were observed between vimentin positivity, loss of tubular VEGF, and loss of peritubular capillaries 4 weeks after I/R. Semiquantitative analysis of (A) VEGF and (B) capillary density (JG12 IHC) from bilateral (n=10), UNX (n=12), and 3/4 NX (n=12) rats 4 weeks after I/R. Significant reductions in VEGF were seen in PTs from 3/4 NX I/R versus other I/R kidneys. A similar pattern was observed for JG12, with 3/4 NX I/R kidneys exhibiting significantly lower levels versus other I/R groups. Semiquantitative analyses of VEGF and JG12 expression in bilateral, UNX and 3/4 NX sham I/R kidneys indicated abundant expression (all scores of five; data not shown). There was a strong inverse correlation between scores for (C) VEGF and vimentin (r2=0.67, P<0.001) and a positive correlation between scores for (D) VEGF and JG12 (r2=0.76, P<0.001). ***P<0.001; **P<0.01 versus respective 3/4 NX I/R group. Values are mean±SEM.
Interestingly, interstitial fibrosis was of greater severity around atrophic tubules of small diameters than similarly atrophic but dilated tubules. We surmise, as have others, that dense fibrosis protects against tubule dilatation.27
Disproportionately Severe TIF in 3/4 NX I/R Rats Is Accompanied by Hypertension and Proteinuria
Figure 10A presents 24-hour mean systolic BP at 10-minute intervals by radiotelemetry in conscious rats averaged over a 1-week interval before I/R and weekly intervals after I/R or sham I/R. Before I/R, BP was modestly higher in 3/4 NX rats compared with other groups (P<0.05). No significant BP increases occurred in bilateral I/R and 3/4 NX sham I/R rats. However, in 3/4 NX I/R rats, BP increased gradually to hypertensive levels 2, 3, and 4 weeks after I/R versus pre-I/R values and increased over corresponding values for other groups (P<0.05). A modest increase (P<0.05) in BP was also seen at 4 weeks post-I/R in UNX rats. Rats with 3/4 NX developed progressively increasing proteinuria after I/R (Figure 10B), greater than other groups at 4 weeks (P<0.05). Notably, 3 of 12 3/4 NX I/R rats with the highest proteinuria and averaged BP displayed hyalinosis, FSGS, or capsular adhesions in 5%–10% of glomeruli (Supplemental Figure 8) in addition to severe TIF. Most glomeruli in other rats with smaller BP increases were normal or showed only minimal abnormalities; 4 weeks after sham I/R only or 1 week after I/R, all glomeruli in 3/4 NX rats were larger, but otherwise normal (not shown).
Figure 10.
Preexistent RMR promotes the development of hypertension and proteinuria after AKI. (A) Systolic BP before and at weekly intervals after I/R injury. Systolic BP, as determined by radiotelemetric methods, was modestly but significantly higher in the 3/4 NX groups pre-I/R (#P<0.05 versus UNX I/R and bilateral I/R at similar time points). After I/R, systolic BP increased progressively in 3/4 NX rats (†P<0.05 versus all other groups at similar time points and versus 3/4 NX pre-I/R values). Systolic BP was modestly but significantly elevated in UNX I/R rats at 4 weeks post-I/R (*P<0.05 versus respective pre-I/R values). No significant changes in systolic BP were observed in bilateral I/R and 3/4 NX sham I/R rats. (B) Proteinuria before and 2 and 4 weeks after I/R. Progressive proteinuria (milligrams per day) developed in 3/4 NX rats after I/R, with values becoming significant at 4 weeks post-I/R (#P<0.05 versus all other groups at similar time points). No significant increases in proteinuria were observed in all other groups. Values are mean±SEM.
Discussion
Our data provide the first experimental verification of the emerging clinical concept that loss of renal mass by prior disease adversely affects the outcome of superimposed AKI. Substantially greater TIF was observed at 4 weeks after I/R injury in rats with 75% RMR compared with rats with no or 50% RMR. In general, TIF and nephron loss after AKI have been observed to parallel the severity of the initial AKI.2,9,28,46 However, our results show that it was not the case in the present studies. The extent of RMR did not affect the severity of the initial acute injury after I/R, which is reflected by lack of differences in SCr, the histologic severity of tubular necrosis at 3 days after I/R, or vimentin positivity during early dedifferentiation and regeneration at 7 days after I/R. However, at 4 weeks after I/R, when tubules should recover by redifferentiation, far greater numbers of tubules in the 3/4 NX I/R group continued to express a dedifferentiated vimentin-positive phenotype. We reported previously that such vimentin-positive tubules associated with fibrosis are growth-arrested but vicariously continue to signal through proliferation-associated pathways, exhibit undifferentiated morphology by electron microscopy, and lack IHC markers for epithelial differentiation.25,26,47,48 We now provide quantitative data to support the strong inverse relationships between vimentin positivity and expression of the differentiation marker (AQP1) or the differentiation determinant (PTEN). Like in our previous reports,25,26,47,48 the current data also indicate that tubules with the failed differentiation phenotype produce profibrotic peptides and give rise to surrounding fibrosis. Accordingly, scores for vimentin-positive tubules and TIF were strongly correlated 4 weeks after I/R in all groups, indicating a similar pathogenesis that is quantitatively more severe in 3/4 NX I/R versus other I/R kidneys. Collectively, these data support the concept developed earlier that failed differentiation of tubule epithelium after AKI with persistent proliferative signaling and production of profibrotic peptides is likely to be related to the development of fibrosis around tubules.9 Furthermore, these data suggest that severe RMR impairs the orderly recovery of a greater proportion of tubules regenerating after I/R by compromising their redifferentiation, thereby promoting TIF. Such a mechanism could explain the consistently observed impairment or nonrecovery of kidney function in outcome analysis studies of human CKD with additional superimposed AKI.
The mechanisms responsible for the enhanced failure of regenerating tubules to recover and redifferentiate after AKI in rats with severe RMR remain to be definitively established. Although increased tubule metabolic workload, hypertrophy, and/or altered oxygen metabolism associated with severe RMR21,40,49 may be insufficient by themselves to produce progressive TIF in the absence of glomerular hypertension,17–19 they may, nevertheless, be able to compromise tubule recovery after AKI. In this context, our finding of severely reduced tubular VEGF expression after I/R in 3/4 NX rats suggests a potential pathway. Although pericytes as well as tubules produce VEGF and may regulate capillary integrity,42 overwhelming evidence to date suggests that tubules are important sources of VEGF and that the angiogenic effects of tubular VEGF are believed to be critical for the preservation and maintenance of peritubular vasculature.36–39,41,42,45,50,51 Therefore, the loss of tubular VEGF as a component of the failed differentiation phenotype may be responsible for the severely reduced peritubular capillaries in the 3/4 NX I/R rats. The strong inverse correlations between vimentin positivity and VEGF expression and in turn, between VEGF and capillary density support such inferences. These observations are consistent with previous studies suggesting that compromised VEGF signaling and diminished microvascular density may contribute to fibrotic kidney disease.36–38,40–45,50 It is, therefore, reasonable to hypothesize that early loss of capillary density could lead to local tissue hypoxia that could prevent injured tubules from redifferentiation. A progressively worsening vicious cycle of tubule damage and capillary rarefaction with tissue hypoxia in such microenvironments may increase the likelihood that tubules do not recover.9
Most prior investigations of the relationships between severe RMR and AKI were limited to the examination of acute injury, usually shorter than 40 minutes in duration, 24 hours after I/R.14,16 In the only study where the impact of RMR on subsequent AKI was studied over longer periods, subtotal RMR by UNX+ablation/infarction 10 weeks before I/R decreased AKI severity compared with I/R of both intact kidneys, but AKI after I/R in UNX kidneys was more severe.15 However, there were no differences in repair, which was essentially complete by 10 days in all groups. Several explanations exist for the discrepancy between this study15 and our study, and they include the relatively modest AKI severity (peak SCr of only approximately1.5 mg/dl), the use of an RMR model known to cause hypertension, the use of nephropathy-resistant Lewis rats,52,53 the use of renoprotective isoflurane anesthetic,54,55 and the question of whether core body temperature, a modulator of AKI severity,28 was maintained at 37°C in the study by Vercauteren et al.15
Although our studies did not address CKD progression after I/R, the observed adverse effects of severe RMR on recovery after AKI may, nevertheless, provide clues to potential mechanisms of accelerated long-term CKD progression after AKI. One AKI episode, even with residual fibrosis, intuitively seems insufficient to initiate progression without prior CKD/RMR. Without additional injury events, sites of damage become scars, and surviving nephrons would maintain function if present in adequate numbers. Consistent with such concepts, progressive CKD was shown in bilateral AKI models after repeated (not single) injury episodes.56,57 However, with severe parenchymal loss by prior CKD or surgical RMR in our model, a single episode of AKI may be sufficient to result in severe TIF. In this context, the development of hypertension in previously normotensive UNX and 3/4 NX rats after AKI is relevant. Hypertension developed gradually 2–4 weeks after I/R and was restricted to rats that had not only additional parenchymal loss by TIF but also, severe losses of capillary density. These considerations make it likely that hypertension developed secondarily to severe microcirculatory deficits through mechanisms similar to those mechanisms reported for salt-sensitive hypertension occurring late in the bilateral I/R model.58,59 These studies found that losses of capillary density caused by I/R were prevented by the administration of VEGF-121, an early intervention that also preempted the salt-sensitive hypertension and fibrosis that developed secondarily to later administration of high salt.60
In any event, regardless of its precise pathogenesis, the development of hypertension in the RMR setting is likely to have significant long-term effects. Hypertension adversely affects the progression of established CKD.17–19,61,62 Enhanced glomerular BP transmission of elevated systemic BP caused by impairment in renal autoregulation after RMR results in progressive proteinuria, glomerulosclerosis, and incremental loss of additional nephrons.61,62 Indeed, AKI leads to CKD progression, with increasing proteinuria and glomerulosclerosis, in rats with preexistent 50% RMR (i.e., UNX).37,63–65 Rapid development of proteinuria and glomerular pathology in the most severely hypertensive 3/4 NX I/R rats in our study is consistent with such interpretations. In this context, bilateral and UNX I/R kidneys showed similar numbers of tubules with failed differentiation and similar TIF scores when considered as fractions of available renal mass, but UNX I/R rats (not bilateral I/R rats) developed proteinuria, glomerulosclerosis, TIF, and renal dysfunction after many months.37,63 Therefore, it seems possible that the long-term consequences of AKI in RMR settings depend on not only the extent of tubules lost by failed differentiation and TIF but, also, the hemodynamic effects of RMR additionally imposed by AKI (hypertension and impaired autoregulation), the severity of which would be governed by the amounts of functional renal mass remaining after AKI.
In summary, our studies show striking adverse effects of severe RMR on the ability of kidney tubules to recover and redifferentiate after AKI. The defective tubules that are produced have profibrotic properties that are associated with TIF. Failure of recovering tubules to differentiate during recovery from AKI with the associated TIF and reduced peritubule capillary density may also be an antecedent cause for the development of hypertension in previously normotensive settings of CKD. Of particular relevance, the current findings support a recent population-based cohort study implicating an association between poor recovery from AKI and increased risk of CKD progression.66
Concise Methods
CKD and AKI Models
Male Sprague–Dawley rats (Charles River) were obtained at 6–8 weeks of age and provided a standard rat chow (1.0% NaCl; Purina) and drinking water ad libitum. The animals were cared for in accordance with National Institutes of Health and institutional guidelines, and studies were approved by the Institutional Animal Care and Use Committee of Loyola University and Hines Veterans Administration Hospital. Mice were prepared for BP radiotelemetry (sampled every 10 minutes [24 h/d]).17 During the same surgery, kidneys were left intact in one group of rats (bilateral; n=20), whereas the remaining rats underwent normotensive RMR by right UNX (n=22) or right UNX+surgical excision of both poles of the left kidney (3/4 NX; n=27).17 After 14–18 days of recovery and compensatory renal adaptations,67 body weight, BP, SCr, and 24-hour protein excretion were measured. After this baseline assessment, rats were anesthetized (50 mg/kg sodium pentobarbital), placed on a servo-controlled heated surgical table to maintain body temperature at 37°C, and subjected to a 40-minute I/R through a clamp placed on the left (UNX I/R and 3/4 NX I/R groups) or left and right (bilateral I/R group) renal pedicles.26 For the I/R experiment, after the initial clamping of the renal pedicle, the abdominal incision was closed for the 40-minute duration to ensure that the entire kidney was maintained at 37°C. Kidneys were monitored for adequate reflow on clamp release, and rats recovered on a warming table until conscious.
Experimental Groups
Different groups of rats were studied at three time points after I/R. To investigate whether underlying RMR alters the severity of AKI, one group of bilateral I/R (n=5), one group of UNX I/R (n=5), and one group of 3/4 NX I/R (n=5) rats were euthanized at 3 days post-I/R for the assessment of tubular necrosis. Separate groups of bilateral I/R (n=5), UNX I/R (n=5), and 3/4 NX I/R (n=5) rats were euthanized at 7 days post-I/R for the assessment of regenerating vimentin-positive tubules as an additional index of AKI severity. Finally, a third group of bilateral I/R (n=10), a third group of UNX I/R (n=12), a third group of 3/4 NX I/R (n=12), and a group of 3/4 NX sham I/R (n=5) rats were followed for 4 weeks after I/R to assess the impact of RMR on recovery from AKI. In addition to continuous BP measurement, proteinuria (sulfosalicyclic acid method) and SCr (QuantiChrom Creatinine Assay Kit; BioAssay Systems, Hayward, CA) were monitored at various time points over the 4-week period in this group of animals. Kidneys were perfusion-fixed and harvested from rats at the end of the study. The extent of renal injury was assessed by the semiquantitation of TIF (vide infra).
Morphology and IHC
At all time points after I/R, rat kidneys were perfusion-fixed with periodic acid-lysine-paraformaldehyde, dehydrated in graded ethyl alcohol, and processed into paraffin as previously described.26,48 Deparaffinized sections were stained with Hematoxylin and Eosin, periodic acid–Schiff and Hematoxylin, and Masson’s Trichrome stain. Sections stained with periodic acid–Schiff and Hematoxylin were used to score tubular necrosis in kidneys harvested 3 days after I/R. Acute tubular necrosis was assessed semiquantitatively on a scale from zero to five, with zero indicating no evidence of tubular necrosis. Scores=1–5 represented visual assessment of the percent distribution of necrotic cells in tubules present in an entire cross-section in a quintile distribution. The blinded analysis was done by one of the investigators (M.A.V.). Sections stained with Masson’s Trichrome were similarly used to allocate TIF grades (scored zero to five, with zero being no evidence of TIF) on kidneys harvested 4 weeks after I/R. Percent distribution of areas involved by TIF, as described above for the distribution for necrotic cells, was visually assessed (by M.A.V.). It has previously been shown that visual estimation of the percentage of kidney tissue involved by fibrosis on Masson’s Trichrome–stained slides correlates well with morphometric techniques.68 For IHC, deparaffinized sections were heated to 99–100°C in 1 mM Tris⋅EDTA (pH 8.0) for 20–30 minutes, and endogenous peroxidase activity was neutralized with 3% H2O2 in water. Sections were blocked with 2.5% horse serum and incubated overnight with primary antibodies at 4°C. Primary antibodies and reagents were vimentin (clone V9; Thermo-Fisher, Waltham, MA); phospho-c-Jun, c-Jun (60A8; Ser63 54B3), and PTEN (clone 138G6; Cell Signaling, Danvers, MA); Na+, K+-ATPase α-subunit (DSHB, Iowa City, IA); PDGF-B LS-C112205 (LSBIO, Seattle, WA); connective tissue growth factor, sc-14939, VEGF, Clone VG1, sc-53462, and AQP1 (B-11) sc-25287 (Santa Cruz Biotechnology, Santa Cruz, CA); TGFβ1 AHP1734 (AbD Serotec, Raleigh, NC); phytohaemagglutinin-E–AP lectin conjugate (EY Laboratories, Inc., San Mateo, CA); ImmPRESS horseradish peroxidase polymer-conjugated secondary antibodies and ImmPACT DAB reagent (Vector Labs, Burlingame, CA); and MACH 2 mouse and rabbit AP-Polymer Detection systems and Warp Red Chromogen (Biocare Medical, Concord, CA). Epithelium aminopeptidase P (rat) monoclonal antibody (JG12) was a gift from Dontscho Kerjaschki. Incubation with primary antibody was followed by exposure to ImmPRESS horseradish peroxidase polymer–conjugated secondary antibodies (Vector Labs) as previously described.26 Tubules in kidneys processed by IHC were graded semiquantitatively on a scale from zero to five, with zero indicating the absence of specific antigens within tubules. Percentile distribution of tubule mass with the antigen in entire cross-sections was assessed by M.A.V. as described above for necrosis and TIF.
Statistical Analyses
Results are mean±SEM. Statistical comparisons between groups were performed using one-way ANOVA, repeated measures ANOVA, and paired and unpaired t tests as appropriate. A Newman–Keuls post hoc test was used for multiple comparisons when appropriate. All semiquantitative data were log-transformed [log(1+x)] before statistical analysis. Linear regression analysis was used to calculate the slope of the relationship between variables. A P<0.05 value was considered significant.
Disclosures
None.
Supplementary Material
Acknowledgments
We acknowledge the technical support of Theresa Herbst and Hector Licea-Vargas and the secretarial support of Martha Prado.
This work was supported by Office of Research and Development of the Department of Veterans Affairs Career Development Award 1K2BX001285 (to A.J.P.), an Office of Research and Development of the Department of Veterans Affairs Merit Award (to K.A.G.), and National Institute of Diabetes and Digestive and Kidney Diseases Grants DK61653 (to K.A.G.) and DK40426 (to A.K.B.).
Some of these results were presented in abstract form at the American Society of Nephrology Annual Meeting held November 8–13, 2011, in Philadelphia, PA.
Footnotes
Published online ahead of print. Publication date available at www.jasn.org.
This article contains supplemental material online at http://jasn.asnjournals.org/lookup/suppl/doi:10.1681/ASN.2013040359/-/DCSupplemental.
References
- 1.Bucaloiu ID, Kirchner HL, Norfolk ER, Hartle JE, 2nd, Perkins RM: Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 81: 477–485, 2012 [DOI] [PubMed] [Google Scholar]
- 2.Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE: The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 79: 1361–1369, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR: Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 53: 961–973, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hsu CY: Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens 16: 221–226, 2007 [DOI] [PubMed] [Google Scholar]
- 5.Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20: 223–228, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordoñez JD, Hsu CY: Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76: 893–899, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG, University of Toronto Acute Kidney Injury Research Group : Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302: 1179–1185, 2009 [DOI] [PubMed] [Google Scholar]
- 8.Hsu CY, Ordoñez JD, Chertow GM, Fan D, McCulloch CE, Go AS: The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 74: 101–107, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK: Acute kidney injury: A springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298: F1078–F1094, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Okusa MD, Chertow GM, Portilla D, Acute Kidney Injury Advisory Group of the American Society of Nephrology : The nexus of acute kidney injury, chronic kidney disease, and World Kidney Day 2009. Clin J Am Soc Nephrol 4: 520–522, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Rifkin DE, Coca SG, Kalantar-Zadeh K: Does AKI truly lead to CKD? J Am Soc Nephrol 23: 979–984, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Singh P, Rifkin DE, Blantz RC: Chronic kidney disease: An inherent risk factor for acute kidney injury? Clin J Am Soc Nephrol 5: 1690–1695, 2010 [DOI] [PubMed] [Google Scholar]
- 13.Hsu CY: Yes, AKI truly leads to CKD. J Am Soc Nephrol 23: 967–969, 2012 [DOI] [PubMed] [Google Scholar]
- 14.Singh P, Blantz RC, Rosenberger C, Gabbai FB, Schoeb TR, Thomson SC: Aberrant tubuloglomerular feedback and HIF-1α confer resistance to ischemia after subtotal nephrectomy. J Am Soc Nephrol 23: 483–493, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Vercauteren SR, Ysebaert DK, De Greef KE, Eyskens EJ, De Broe ME: Chronic reduction in renal mass in the rat attenuates ischemia/reperfusion injury and does not impair tubular regeneration. J Am Soc Nephrol 10: 2551–2561, 1999 [DOI] [PubMed] [Google Scholar]
- 16.Zager RA, Baltes LA: Progressive renal insufficiency induces increasing protection against ischemic acute renal failure. J Lab Clin Med 103: 511–523, 1984 [PubMed] [Google Scholar]
- 17.Griffin KA, Picken M, Bidani AK: Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 4: 2023–2031, 1994 [DOI] [PubMed] [Google Scholar]
- 18.Griffin KA, Picken MM, Bidani AK: Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat. Kidney Int 65: 209–218, 2004 [DOI] [PubMed] [Google Scholar]
- 19.Griffin KA, Picken MM, Churchill M, Churchill P, Bidani AK: Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat. J Am Soc Nephrol 11: 497–506, 2000 [DOI] [PubMed] [Google Scholar]
- 20.Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241: F85–F93, 1981 [DOI] [PubMed] [Google Scholar]
- 21.Nath KA, Croatt AJ, Hostetter TH: Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol 258: F1354–F1362, 1990 [DOI] [PubMed] [Google Scholar]
- 22.Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I: Effects of antihypertensive drugs on glomerular morphology. Kidney Int 36: 626–635, 1989 [DOI] [PubMed] [Google Scholar]
- 23.Bonventre JV: Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14[Suppl 1]: S55–S61, 2003 [DOI] [PubMed] [Google Scholar]
- 24.Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199–2210, 2003 [DOI] [PubMed] [Google Scholar]
- 25.Geng H, Lan R, Singha PK, Gilchrist A, Weinreb PH, Violette SM, Weinberg JM, Saikumar P, Venkatachalam MA: Lysophosphatidic acid increases proximal tubule cell secretion of profibrotic cytokines PDGF-B and CTGF through LPA2- and Gαq-mediated Rho and αvβ6 integrin-dependent activation of TGF-β. Am J Pathol 181: 1236–1249, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Lan R, Geng H, Polichnowski AJ, Singha PK, Saikumar P, McEwen DG, Griffin KA, Koesters R, Weinberg JM, Bidani AK, Kriz W, Venkatachalam MA: PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis. Am J Physiol Renal Physiol 302: F1210–F1223, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Suzuki T, Kimura M, Asano M, Fujigaki Y, Hishida A: Role of atrophic tubules in development of interstitial fibrosis in microembolism-induced renal failure in rat. Am J Pathol 158: 75–85, 2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16: 535–543, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Yang L, Humphreys BD, Bonventre JV: Pathophysiology of acute kidney injury to chronic kidney disease: Maladaptive repair. Contrib Nephrol 174: 149–155, 2011 [DOI] [PubMed] [Google Scholar]
- 30.Fujigaki Y, Sakakima M, Sun Y, Fujikura T, Tsuji T, Yasuda H, Hishida A: Cell division and phenotypic regression of proximal tubular cells in response to uranyl acetate insult in rats. Nephrol Dial Transplant 24: 2686–2692, 2009 [DOI] [PubMed] [Google Scholar]
- 31.Gröne HJ, Weber K, Gröne E, Helmchen U, Osborn M: Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol 129: 1–8, 1987 [PMC free article] [PubMed] [Google Scholar]
- 32.Hatzinger PB, Chen Q, Dong LQ, Stevens JL: Alterations in intermediate filament proteins in rat kidney proximal tubule epithelial cells. Biochem Biophys Res Commun 157: 1316–1322, 1988 [DOI] [PubMed] [Google Scholar]
- 33.Ward JM, Stevens JL, Konishi N, Kurata Y, Uno H, Diwan BA, Ohmori T: Vimentin metaplasia in renal cortical tubules of preneoplastic, neoplastic, aging, and regenerative lesions of rats and humans. Am J Pathol 141: 955–964, 1992 [PMC free article] [PubMed] [Google Scholar]
- 34.Witzgall R, Brown D, Schwarz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93: 2175–2188, 1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Park KM, Chen A, Bonventre JV: Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 276: 11870–11876, 2001 [DOI] [PubMed] [Google Scholar]
- 36.Basile DP, Donohoe D, Roethe K, Osborn JL: Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281: F887–F899, 2001 [DOI] [PubMed] [Google Scholar]
- 37.Basile DP, Donohoe DL, Roethe K, Mattson DL: Chronic renal hypoxia after acute ischemic injury: Effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol 284: F338–F348, 2003 [DOI] [PubMed] [Google Scholar]
- 38.Basile DP, Fredrich K, Chelladurai B, Leonard EC, Parrish AR: Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am J Physiol Renal Physiol 294: F928–F936, 2008 [DOI] [PubMed] [Google Scholar]
- 39.Dimke HS, Sparks MA, Frische S, Coffman TM, Quaggin SE: Tubular Vegfa is required for renal microvasculature and oxygen sensing [Abstract]. Presented at the American Heart Association High Blood Pressure Research Conference, New Orleans, LA, September 11–14, 2013 [Google Scholar]
- 40.Fine LG, Bandyopadhay D, Norman JT: Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int Suppl 75: S22–S26, 2000 [PubMed] [Google Scholar]
- 41.Kang DH, Johnson RJ: Vascular endothelial growth factor: A new player in the pathogenesis of renal fibrosis. Curr Opin Nephrol Hypertens 12: 43–49, 2003 [DOI] [PubMed] [Google Scholar]
- 42.Lin SL, Chang FC, Schrimpf C, Chen YT, Wu CF, Wu VC, Chiang WC, Kuhnert F, Kuo CJ, Chen YM, Wu KD, Tsai TJ, Duffield JS: Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 178: 911–923, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Mimura I, Nangaku M: The suffocating kidney: Tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol 6: 667–678, 2010 [DOI] [PubMed] [Google Scholar]
- 44.Schrimpf C, Xin C, Campanholle G, Gill SE, Stallcup W, Lin SL, Davis GE, Gharib SA, Humphreys BD, Duffield JS: Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 23: 868–883, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Yuan HT, Li XZ, Pitera JE, Long DA, Woolf AS: Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha. Am J Pathol 163: 2289–2301, 2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210–4221, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Geng HL, Lan R, Singha PK, Saikumar P, Weinberg JM, Venkatachalam MA: Lysophosphatidic acid (LPA) transactivates epidermal growth factor receptors (EGFR) via LPAR1/Gαi/o signaling to potentiate LPAR2/Gαq/αvβ6 integrin dependent TGFβ signaling and increase the production of PDGF-B and CTGF by proximal tubule (PT) cells [Abstract]. Presented at the American Society of Nephrology Annual Meeting, Atlanta, GA, November 5–10, 2013 [Google Scholar]
- 48.Geng H, Lan R, Wang G, Siddiqi AR, Naski MC, Brooks AI, Barnes JL, Saikumar P, Weinberg JM, Venkatachalam MA: Inhibition of autoregulated TGFbeta signaling simultaneously enhances proliferation and differentiation of kidney epithelium and promotes repair following renal ischemia. Am J Pathol 174: 1291–1308, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Nangaku M: Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17–25, 2006 [DOI] [PubMed] [Google Scholar]
- 50.Basile DP, Friedrich JL, Spahic J, Knipe N, Mang H, Leonard EC, Changizi-Ashtiyani S, Bacallao RL, Molitoris BA, Sutton TA: Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol 300: F721–F733, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Hakroush S, Moeller MJ, Theilig F, Kaissling B, Sijmonsma TP, Jugold M, Akeson AL, Traykova-Brauch M, Hosser H, Hähnel B, Gröne HJ, Koesters R, Kriz W: Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. Am J Pathol 175: 1883–1895, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Reynolds J, Cook PR, Ryan JJ, Norsworthy PJ, Glazier AM, Duda MA, Evans DJ, Aitman TJ, Pusey CD: Segregation of experimental autoimmune glomerulonephritis as a complex genetic trait and exclusion of Col4a3 as a candidate gene. Exp Nephrol 10: 402–407, 2002 [DOI] [PubMed] [Google Scholar]
- 53.Szabo AJ, Muller V, Chen GF, Samsell LJ, Erdely A, Baylis C: Nephron number determines susceptibility to renal mass reduction-induced CKD in Lewis and Fisher 344 rats: Implications for development of experimentally induced chronic allograft nephropathy. Nephrol Dial Transplant 23: 2492–2495, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kim M, Ham A, Kim JY, Brown KM, D’Agati VD, Lee HT: The volatile anesthetic isoflurane induces ecto-5′-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury. Kidney Int 84: 90–103, 2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW: Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 101: 1313–1324, 2004 [DOI] [PubMed] [Google Scholar]
- 56.Grgic I, Campanholle G, Bijol V, Wang C, Sabbisetti VS, Ichimura T, Humphreys BD, Bonventre JV: Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 82: 172–183, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Nath KA, Croatt AJ, Haggard JJ, Grande JP: Renal response to repetitive exposure to heme proteins: Chronic injury induced by an acute insult. Kidney Int 57: 2423–2433, 2000 [DOI] [PubMed] [Google Scholar]
- 58.Pechman KR, De Miguel C, Lund H, Leonard EC, Basile DP, Mattson DL: Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 297: R1358–R1363, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Spurgeon-Pechman KR, Donohoe DL, Mattson DL, Lund H, James L, Basile DP: Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. Am J Physiol Renal Physiol 293: F269–F278, 2007 [DOI] [PubMed] [Google Scholar]
- 60.Leonard EC, Friedrich JL, Basile DP: VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am J Physiol Renal Physiol 295: F1648–F1657, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Bidani AK, Griffin KA: Pathophysiology of hypertensive renal damage: Implications for therapy. Hypertension 44: 595–601, 2004 [DOI] [PubMed] [Google Scholar]
- 62.Bidani AK, Schwartz MM, Lewis EJ: Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am J Physiol 252: F1003–F1010, 1987 [DOI] [PubMed] [Google Scholar]
- 63.Cruzado JM, Torras J, Riera M, Herrero I, Hueso M, Espinosa L, Condom E, Lloberas N, Bover J, Alsina J, Grinyó JM: Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia. Am J Physiol Renal Physiol 279: F259–F269, 2000 [DOI] [PubMed] [Google Scholar]
- 64.Pagtalunan ME, Olson JL, Meyer TW: Contribution of angiotensin II to late renal injury after acute ischemia. J Am Soc Nephrol 11: 1278–1286, 2000 [DOI] [PubMed] [Google Scholar]
- 65.Pagtalunan ME, Olson JL, Tilney NL, Meyer TW: Late consequences of acute ischemic injury to a solitary kidney. J Am Soc Nephrol 10: 366–373, 1999 [DOI] [PubMed] [Google Scholar]
- 66.Pannu N, James M, Hemmelgarn B, Klarenbach S, Alberta Kidney Disease Network : Association between AKI, recovery of renal function, and long-term outcomes after hospital discharge. Clin J Am Soc Nephrol 8: 194–202, 2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Chamberlain RM, Shirley DG: Time course of the renal functional response to partial nephrectomy: Measurements in conscious rats. Exp Physiol 92: 251–262, 2007 [DOI] [PubMed] [Google Scholar]
- 68.Farris AB, Adams CD, Brousaides N, Della Pelle PA, Collins AB, Moradi E, Smith RN, Grimm PC, Colvin RB: Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol 22: 176–186, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.










